News - BioHarvest Sciences

News Room

April 29, 2026

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate “Two-Lens” Growth Strategy

March 31, 2026

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

March 31, 2026

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

March 17, 2026

BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

March 5, 2026

BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy

March 3, 2026

BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026

December 18, 2025

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

December 3, 2025

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

November 16, 2025

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

November 13, 2025

BIOHARVEST SCIENCES ANNOUNCES CLOSING OF $19.9 MILLION UPSIZED PUBLIC OFFERING OF COMMON STOCK AND EXERCISE OF UNDERWRITER’S OPTION TO PURCHASE ADDITIONAL SHARES

November 6, 2025

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

October 30, 2025

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

December 11, 2024

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of  Ingredients through Botanical Synthesis Technology

November 25, 2024

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

November 25, 2024

BioHarvest Launches VINIA SuperFood Functional Tea Line

November 21, 2024

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

November 18, 2024

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 p.m. Eastern Time

November 12, 2024

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

December 27, 2023

BIOHARVEST SCIENCES INC. CLOSES FINAL TRANCHE OF OVERSUBSCRIBED $13.5M PRIVATE PLACEMENT

December 13, 2023

BIOHARVEST SCIENCES ANNOUNCES MAJOR PRODUCT LAUNCH OF VINIA-BASED FUNCTIONAL COFFEES

December 1, 2023

BIOHARVEST SCIENCES TO HOST VIRTUAL SHAREHOLDER UPDATE DECEMBER 13, 2023, 2:30pm ET

November 29, 2023

BIOHARVEST SCIENCES REPORTS Q3 2023 REVENUE DEMONSTRATING CONTINUED GROWTH MOMENTUM

October 30, 2023

BIOHARVEST SCIENCES INC. ANNOUNCES $11.78M RAISED IN FIRST TRANCHE OF $13.5M PRIVATE PLACEMENT

October 10, 2023

HEALTH CANADA GRANTS BIOHARVEST SCIENCES LICENSE FOR VINIA SALES IN CANADA

December 29, 2022

BIOHARVEST SCIENCES INC. 2022 CEO LETTER TO SHAREHOLDER PARTNERS

December 15, 2022

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE THIRD TRANCHE OF CONVERTIBLE NOTES

December 15, 2022

BIOHARVEST SCIENCES INC. PROJECTS 2023 REVENUE TO GROW 3.0X-3.5X TO A RANGE OF USD $17M-$20M

November 16, 2022

ROYAL EMERALD PHARMACEUTICALS PARTNERS WITH BIOHARVEST SCIENCES TO SUPPLY DISRUPTIVE CANNABIS SOLUTIONS TO COMPANIES CONDUCTING FDA-APPROVED MEDICAL RESEARCH

November 15, 2022

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES AND EXPECTS THE OFFERING TO BE OVERSUBSCRIBED AND TO CLOSE AN ADDITIONAL TRANCHE OF UP TO $3 MILLION BY DECEMBER 15, 2022

October 25, 2022

BIOHARVEST INTRODUCES ITS 1ST CANNABIS BREAKTHROUGH COMPOSITION WITH MAJOR MEDICAL AND COMMERCIAL IMPLICATIONS

December 30, 2021

BIOHARVEST SCIENCES INC. 2021 CEO LETTER TO SHAREHOLDER PARTNERS

December 12, 2021

UNPRECEDENTED BIOHARVEST MEDIA COVERAGE! Plus a request from CEO Ilan Sobel

December 8, 2021

BIOHARVEST SCIENCES INC. PRODUCES SIGNIFICANT AMOUNT OF CANNABIS WITHOUT GROWING THE CANNABIS PLANT

December 1, 2021

BIOHARVEST SCIENCES APPOINTS ASTRONAUT CHRIS HADFIELD TO THE BOARD OF ADVISORS

November 30, 2021

BHSC NOVEMBER NEWSLETTER

November 29, 2021

BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS

December 31, 2020

BioHarvest Sciences Inc. CEO’s 2020 End of Year Message to Shareholders

December 23, 2020

BioHarvest Sciences Inc. and Batory Foods announce the first significant B2B VINIA sale in the US

December 9, 2020

BIOHARVEST SCIENCES INC. Increases VINIA® Israel Sales Order Forecast for 4th Quarter – 2020

November 18, 2020

Bioharvest Sciences Inc. Delivers a 380% Increase in monthly E-Commerce Revenue with its 2020 Launch of Vinia® B2c On-Line Business in Israel

November 13, 2020

Bioharvest Sciences Inc.’s Appoints Nathaniel Averill as VP Of Manufacturing, QA & Supply Chain.

November 12, 2020